The prevention of neonatal group B streptococcal disease: A report by a working group of the Medical Screening Society

Keyphrases

• Group B Streptococcus Infection 100%
• Medical Screening 100%
• Levels of Prevention 66%
• Risk Factors 33%
• Penicillin 33%
• Neonate 33%
• Number of Deaths 33%
• Group B Streptococcus 33%
• Early Onset 33%
• Disability 33%
• Randomized Trial 33%
• Late-onset 33%
• Screening Performance 33%
• Streptococcus Agalactiae 33%
• Effective Means 33%
• Bacterial Sepsis 33%
• High-risk Pregnancy 33%
• Alternative Means 33%
• Neonatal Meningitis 33%
• Microbiological Factors 33%
• Lancefield Group B 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Streptococcus Agalactiae 100%
• Group B Streptococcal Infection 100%
• Diseases 100%
• Sepsis 50%
• Meningitis 50%
• High Risk Pregnancy 50%
• Penicillin 50%

Immunology and Microbiology

• Streptococcus Agalactiae 100%
• Penicillin 25%
• Neonatal Meningitis 25%
• Bacterial Sepsis 25%